Switzerland / South Africa / United States / India / / /
Event
M&A / FDA Phase / /
Facility
National Institute of Allergy / Columbia University / / /
IndustryTerm
PREVENTION OF HIV / HIV Prevention / clinical management / HIV treatment / AIDS Care / prevention technologies / /
MedicalCondition
TB / HIV / HBV / virus hepatitis C / emtricitabine hepatitis B / acquired immunodeficiency syndrome / clinical disease / hepatitis C / hepatitis B / liver disease / infections / HIV infection / cancers / malaria / acute HIV infection / diabetes / cardiovascular disease / HCV / STRATEGIC USE OF ANTIRETROVIRALS FOR TREATMENT AND PREVENTION OF HIV INFECTION / AIDS / Paediatric HIV infection / chronic active hepatitis / HIV/AIDS / /
MedicalTreatment
antiretroviral therapy / counselling / drug therapy / /
Organization
U.S. Department of Health and Human Services / National Institute of Health / World Health Organization / International Center for AIDS Care / Federal Trade Commission / UNICEF WHO / Columbia University / New York / Centers for Disease Control and Prevention / Treatment Programs / National Institute of Allergy and Infectious Diseases / civil society / United Nations / Center for Research for Mothers and Children / World Health Organization Department of HIV/AIDS / Centre for the AIDS Programme of Research in South Africa / UNAIDS / /
Person
TDF TB UNAIDS UNICEF / Thomas Mertenskoetter / Gottfried Hirnschall / Reuben Granich / Rachel Baggaley / Ying-Ru Lo / Andrew Ball / Nathan Shaffer / Nathan Ford / Marco Vitoria / Craig McClure / Médecins Sans Frontières / Andreas Reis / EFV FTC HBV HCV / / /
hiv/aids Programme THE STRATEGIC USE OF ANTIRETROVIRALS FOR TREATMENT AND PREVENTION OF HIV INFECTION For more information, contact: World Health Organization